176 related articles for article (PubMed ID: 10091528)
21. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
Chłopicki S; Gryglewski RJ
Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
[TBL] [Abstract][Full Text] [Related]
22. [Primary prevention trials performed with statins prior to the JUPITER trial].
Baykan M
Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():14-7. PubMed ID: 19553757
[TBL] [Abstract][Full Text] [Related]
23. [HMG-CoA reductase inhibitor and risk of stroke].
Endres M; Laufs U
Nervenarzt; 1998 Aug; 69(8):717-21. PubMed ID: 9757426
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective actions of acute HMG-CoA reductase inhibition in the setting of myocardial infarction.
Jones SP; Lefer DJ
Acta Physiol Scand; 2001 Sep; 173(1):139-43. PubMed ID: 11678736
[TBL] [Abstract][Full Text] [Related]
25. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data.
Crouse JR; Byington RP; Furberg CD
Atherosclerosis; 1998 May; 138(1):11-24. PubMed ID: 9678767
[TBL] [Abstract][Full Text] [Related]
26. [Current knowledge about the effect of HMG-CoA reductase inhibitors].
Gesche M
Dtsch Med Wochenschr; 1998 Jan; 123(5):135. PubMed ID: 9487300
[No Abstract] [Full Text] [Related]
27. Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction.
Muhlestein JB
Drugs Aging; 2004; 21(9):583-95. PubMed ID: 15260513
[TBL] [Abstract][Full Text] [Related]
28. HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?
Valantine HA; Schroeder JS
Circulation; 1997 Sep; 96(5):1370-3. PubMed ID: 9315517
[No Abstract] [Full Text] [Related]
29. HMG-CoA reductase inhibitors in the prevention of stroke.
van Mil AH; Westendorp RG; Bollen EL; Lagaay AM; Blauw GJ
Drugs; 2000 Jan; 59(1):1-6. PubMed ID: 10718096
[TBL] [Abstract][Full Text] [Related]
30. HMG CoA reductase inhibitors.
Feussner G
Curr Opin Lipidol; 1994 Feb; 5(1):59-68. PubMed ID: 15559032
[TBL] [Abstract][Full Text] [Related]
31. [Recent knowledge about the effect of HMG-CoA reductase inhibitors].
Jirak P
Dtsch Med Wochenschr; 1998 Oct; 123(42):1261. PubMed ID: 9809052
[No Abstract] [Full Text] [Related]
32. Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.
Neuhaus O; Stüve O; Zamvil SS; Hartung HP
CNS Drugs; 2005; 19(10):833-41. PubMed ID: 16185093
[TBL] [Abstract][Full Text] [Related]
33. Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia.
Singh S; Zahoor I; Sharma N; Behl T; Kanojia N; Sehgal A; Mohan S; Almoshari Y; Salawi A; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Nov; 29(51):76514-76531. PubMed ID: 36161571
[TBL] [Abstract][Full Text] [Related]
34. Vascular effects of statins in stroke.
Delanty N; Vaughan CJ
Stroke; 1997 Nov; 28(11):2315-20. PubMed ID: 9368582
[TBL] [Abstract][Full Text] [Related]
35. [The role of statins in atherosclerotic peripheral arterial disease].
Mendes Pedro L
Rev Port Cardiol; 2011 Jul; 30(7-8):665-73. PubMed ID: 22005310
[TBL] [Abstract][Full Text] [Related]
36. [Various HMG-CoA reductase inhibitors].
Thiery J; Seidel D
Internist (Berl); 1999 Jan; 40(1):113-4. PubMed ID: 10086311
[No Abstract] [Full Text] [Related]
37. [HMG-CoA reductase inhibitors].
Thiery J; Seidel D
Internist (Berl); 1998 Aug; 39(8):866-7. PubMed ID: 9757391
[No Abstract] [Full Text] [Related]
38. The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in gastrointestinal tract disorders: a comprehensive review.
Cortes-Bergoderi M; Pineda AM; Santana O
J Gastrointestin Liver Dis; 2013 Jun; 22(2):199-204. PubMed ID: 23799219
[TBL] [Abstract][Full Text] [Related]
39. Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly.
Jacobson TA
Drug Saf; 2006; 29(5):421-48. PubMed ID: 16689557
[TBL] [Abstract][Full Text] [Related]
40. [Statins 25 years in preventive cardiology].
Cybulska B; Kłosiewicz Latoszek L
Kardiol Pol; 2012; 70(5):511-6. PubMed ID: 22623249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
